Company Filing History:
Years Active: 2001-2013
Title: Innovations by Stephen John Valazza: Pioneering Pharmaceutical Advancements
Introduction: Stephen John Valazza is an accomplished inventor based in Matawan, NJ, known for his significant contributions to the field of pharmaceuticals. With a portfolio of four patents, he has made strides in drug formulation and delivery.
Latest Patents: Valazza's recent patents include groundbreaking work on galenical formulations of organic compounds. His latest inventions involve a pharmaceutical oral fixed dose combination that encompasses fluvastatin and HPMC, along with other pharmaceutical excipients to ensure color stability during prolonged storage. This innovation reflects his commitment to enhancing medication efficacy and reliability.
Career Highlights: Throughout his career, Stephen Valazza has worked for Novartis AG, a leading global healthcare company that specializes in innovative pharmaceuticals. His role at Novartis has allowed him to focus on developing refined pharmaceutical compositions, contributing to the health sector's advancement through practical solutions.
Collaborations: Valazza collaborates with esteemed colleagues, including Oskar Michael Kalb and Robert Frank Wagner, which has further enriched his research and development efforts. These partnerships reflect a shared mission to innovate and improve patient care through advanced pharmaceutical formulations.
Conclusion: Stephen John Valazza is a notable figure in the field of pharmaceutical innovation, with his inventions poised to contribute positively to healthcare solutions. His dedication to developing new formulations showcases the critical role of inventors like him in enhancing modern medicine, paving the way for future advancements in the industry.